The recombinant protein molecule SA-4-1BBL has been used to enhance the therapeutic efficacy of cancer vaccines with success in pre-clinical animal models, said researchers from the University of Louisville in the US.
from Hindustan Times - health-fitness http://bit.ly/2X4m7bq
Post Top Ad
Friday, 15 February 2019
Immune stimulant molecule shown to prevent cancer: Study
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment